LINC01081: A Drug Target / Disease Biomarker (G101154687)

Target Name: LINC01081

NCBI ID: G101154687

LINC01081

Other Name(s): long intergenic non-protein coding RNA 1081 | TCONS_00024764 | TCONS00024764 | Long intergenic non-protein coding RNA 1081

LINC01081: A Drug Target / Disease Biomarker

LINC01081 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of cell adhesion and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most promising aspects of LINC01081 is its potential as a drug target. LINC01081 has been shown to interact with a variety of molecules, including G protein-coupled receptors (GPCRs), which are a family of membrane-bound proteins that play important roles in cellular signaling.

GPCRs are involved in many different signaling pathways, including sensory perception, neurotransmission, and hormone signaling. They are also involved in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, LINC01081 has been shown to be a promising target for drug development in these fields.

One of the advantages of LINC01081 as a drug target is its expression in a wide range of tissues, including the brain. This makes it a potential target for drugs that can modulate its activity in these tissues, such as those that are used to treat neurological or psychiatric disorders.

In addition, LINC01081 has been shown to be involved in many different signaling pathways that are involved in cancer development. For example, LINC01081 has been shown to be involved in the regulation of the angiogenic factor, which is a protein that promotes blood vessel formation and is often elevated in cancer.

LINC01081 has also been shown to be involved in the regulation of theNotch signaling pathway, which is involved in the development and maintenance of tissues and organs. This suggests that LINC01081 may be a useful target for drugs that are used to treat tissue repair or regeneration disorders.

Another promising aspect of LINC01081 as a drug target is its potential to modulate the activity of other proteins that are involved in disease. For example, LINC01081 has been shown to interact with the protein known as FAK, which is involved in cell adhesion, migration, and invasion.

The results of these studies suggest that LINC01081 may be a promising drug target for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the potential of LINC01081 as a drug and to develop safe and effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 1081

The "LINC01081 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01081 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets